In conclusion, recipients with KT from HCV viremic donors did not show significantly higher risk for CMV infection post KT based on CMV specific CD4+ and CD8 + T cell immune responses compared to recipients with KT from HCV aviremic donors. The gene discussed is CD8A; the disease is cytomegalovirus infection.